WOONSOCKET – CVS/Pharmacy has launched its annual in-store fundraising campaign to support research and treatment of amyotrophic lateral sclerosis, or ALS, an effort that has raised $30 million over the past 11 years.
Through the Advancing Medical Research program, shoppers can donate $1 or $3 at any of the 7,400 CVS and Longs Drug Store locations nationwide through June 29. Supporters can also donate online at www.cvs.com/als.
Funds raised will benefit the ALS Therapy Alliance, a national nonprofit organization advancing ALS research.
Currently there is no known cure for ALS and the cause remains a mystery to researchers. Approximately 30,000 Americans are affected by ALS, with 5,600 new case diagnosed annually.
Past support from CVS has helped fund research into possible gene silencing therapies that seek to end the progression of ALS in patients and may have other clinical applications.
"CVS/pharmacy and its Advancing Medical Research campaign have helped us realize critical advancements in ALS research, including our new research project on gene silencing therapies," ALS Therapy Alliance President Robert H. Brown, Jr. said in a statement.
CVS/Caremark Executive Vice President Jon Roberts said the fundraising efforts fits with the company’s core mission.
“As a pharmacy innovation company that is committed to helping people on their path to better health, CVS Caremark supports organizations and medical research that address important health care issues," he said. “"For the past 11 years, we've been able to make a significant impact in advancing ALS research with support from our colleagues and customers.”